BW
BSX icon

Basepoint Wealth’s Boston Scientific BSX Stock Holding History

Basepoint Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$598 Sell
14
-41
-75% -$2.23K ﹤0.01% 597
2026
Q1 		$3.45K Buy
55
+12
+28% +$960 ﹤0.01% 507
2025
Q4 		$4.1K Buy
+43
New +$4.22K ﹤0.01% 476

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Basepoint Wealth's BSX Position: Q2 2026 in Review

Basepoint Wealth reduced its Boston Scientific (BSX) stake by 75% in Q2 2026, selling an estimated $2.23K and leaving 14 shares worth $598. The position accounts for ﹤0.01% of the portfolio, ranked #597.

Basepoint Wealth first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.1K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Basepoint Wealth held 14 shares of Boston Scientific worth $598 as of Q2 2026.
  • Basepoint Wealth sold 41 Boston Scientific shares in Q2 2026, an estimated $2.23K.
  • Boston Scientific made up ﹤0.01% of Basepoint Wealth's portfolio in Q2 2026, its #597 holding.
  • Basepoint Wealth first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Basepoint Wealth's Boston Scientific position peaked at $4.1K in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.